BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9743157)

  • 1. Complement components and their activation products in pleural fluid.
    Salomaa ER; Viander M; Saaresranta T; Terho EO
    Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
    Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of complement activation between tuberculous and malignant pleuritis].
    Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions.
    Porcel JM; Vives M; Gázquez I; Vicente de Vera MC; Pérez B; Rubio M
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):76-82. PubMed ID: 10654648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP; Ruddy S; Schwartz LB; Moxley G
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.
    Kay AB; Smith AF; McGavin CR; Tuft SB
    J Clin Pathol; 1976 Oct; 29(10):887-9. PubMed ID: 977762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.
    Vives M; Porcel JM; Gázquez I; Pérez B; Rubio M
    Respiration; 2000; 67(4):433-8. PubMed ID: 10940799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of complement breakdown products in tuberculous pleural effusions.
    Lew DP; Perrin LH; Vassalli JD; Suter S; Lambert PH; Waldvogel FA
    Clin Exp Immunol; 1983 Jun; 52(3):569-74. PubMed ID: 6603298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
    Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
    J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in C3, C4, factor B, and related metabolites in septic shock.
    Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
    Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of complement components in pleural fluid: report of 135 cases.
    Shitrit D; Ollech JE; Ollech A; Peled N; Amital A; Fox B; Kramer MR
    Respir Med; 2008 Nov; 102(11):1631-5. PubMed ID: 18653322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-traumatic pleural effusion: demonstration of local complement consumption.
    de Blay F; Aykut-Baturalp A; Goetz J; Purohit A; Perez-Infante A; Hauptmann G; Pauli G
    Respir Med; 1997 Jul; 91(6):373-5. PubMed ID: 9282241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases.
    Pettersson T; Klockars M; Hellström PE
    Thorax; 1982 May; 37(5):354-61. PubMed ID: 6981226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of ferritin, haptoglobin, alpha 1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation.
    Alexandrakis M; Coulocheri S; Kyriakou D; Bouros D; Xirouhaki N; Siafakas N; Castanas E; Eliopoulos GD
    Respir Med; 1997 Oct; 91(9):517-23. PubMed ID: 9415351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
    Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
    J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of determining immunoglobulins, C3 and C4 complement fractions, carcinoembryonic antigen and beta 2 microglobulin in patients with pleural effusion].
    Marel M; Krystůvková O; Svarcová H
    Cas Lek Cesk; 1988 Jun; 127(24):742-6. PubMed ID: 3042148
    [No Abstract]   [Full Text] [Related]  

  • 19. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loculated pleural empyema: identification of complement breakdown products in contiguous sterile pleural fluid.
    Lew PD; Perrin LH; Waldvogel FA; Lambert PH
    Scand J Infect Dis; 1982; 14(3):225-9. PubMed ID: 6924409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.